期刊文献+

下调CD133表达对肝癌细胞恶性生物学行为的影响 被引量:2

Impact of CDl33 expression down-regulation on malignant biological behaviors of liver cancer cells
原文传递
导出
摘要 目的:探讨下调CDl33基因的表达对肝癌细胞生物学行为的影响。方法:将合成的CDl33小干扰核糖核酸分子(si RNA)转染至肝癌SMMC7721细胞并检测转染效率;分别以无转染与转染随机si RNA序列的SMMC7721细胞为空白对照和阴性对照,观察CDl33 si RNA转染后CDl33基因沉默效果,以及SMMC7721细胞主要生物学行为的变化。结果:转染24 h后,转染效率可达到(80.8±9.1)%;与空白对照组比较,CDl33 si RNA转染后的SMMC7721细胞CD133 m RNA及蛋白表达量分别降至空白对照组的10%与35%、细胞增殖活性明显降低、细胞凋亡率明显增加(41.3%vs.25.3%)并出现明显的S期阻滞,集落形成能力明显降低(均P<0.05)。阴性对照组与空白对照组各指标无统计学差异(均P>0.05)。结论:CDl33在肝癌细胞中可能起了癌基因作用,下调其表达能抑制肝癌的恶性生物学行为。 Objective: To investigate the influence of downregulating CD133 gene expression on biological behaviors of human liver cancer cells. Methods: Liver cancer SMMC7721 cells were transfected with the synthesized CD133 siRNA and then transfection efficiency was determined. Using SMMC7721 cells without transfection or transfected with scrambled siRNA sequence as blank control and negative control respectively, the effect of CD 133 gene silencing, and changes in the main biological behaviors in SMMC7721 cells after CD133 siRNA transfection were observed. Results: The transfection efficiency reached (80.8±9.1) % at 24 h after transfection. Compared with blank control group, in SMMC7721 cells after CD133 siRNA transfection, the expression level of CD133 mRNA and protein was reduced to 10% and 35% of the level in blank control group respectivel)5 the proliferative activity was significantly decreased, apoptosis rate was significantly increased with a marked S-phase arrest, and colony-forming ability was significantly decreased (all P〈0.05). All indexes did not show any significant difference between negative control group and blank control group (all P〉0.05). Conclusion: CD133 gene may play an oncogene role in liver cancer cells and down-regulating its expression can suppress the malignant activity of liver cancer.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2016年第1期77-82,共6页 China Journal of General Surgery
基金 江苏省333人才基金项目资助(Ⅲ-2290) 天晴甘美基金项目资助(CFHPC20132020)
关键词 肝细胞 肿瘤干细胞 CDL33 Carcinoma, Hepatocellular Neoplastic Stem Cells CD133
  • 相关文献

参考文献5

二级参考文献57

  • 1Monika Olempska,Patricia Alice Eisenach,Ole Ammerpohl,Hendrik Ungefroren,Fred Fandrich,Holger Kalthoff.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):92-97. 被引量:69
  • 2Shu-Wen Jao MD, MS,Su-Feng Chen PhD,Yaoh-Shiang Lin MD,Yun-Ching Chang PhD,Tsai-Yu Lee MD, MS,Chang-Chieh Wu MD, PhD,Jong-Shiaw Jin MD, PhD,Shin Nieh DDS, MS, MIAC.Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer[J].Annals of Surgical Oncology.2012(11)
  • 3Pierluigi Pilati MD,Simone Mocellin MD,Loris Bertazza PhD,Francesca Galdi PhD,Marta Briarava PhD,Enzo Mammano MD,Emanuela Tessari MD,Giorgio Zavagno MD,Donato Nitti MD.Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis[J].Annals of Surgical Oncology.2012(2)
  • 4Susumu Saigusa MD,Koji Tanaka MD,Yuji Toiyama MD,Takeshi Yokoe MD,Yoshinaga Okugawa MD,Yasuhiro Ioue MD, PhD,Chikao Miki MD, PhD,Masato Kusunoki MD, PhD.Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy[J].Annals of Surgical Oncology.2009(12)
  • 5Naotsugu Haraguchi MD, PhD,Masahisa Ohkuma MD,Hiroyuki Sakashita MD,Shinji Matsuzaki MD,Fumiaki Tanaka MD, PhD,Koshi Mimori MD, PhD,Yukio Kamohara MD, PhD,Hiroshi Inoue MD, PhD,Masaki Mori MD, PhD.CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells[J].Annals of Surgical Oncology.2008(10)
  • 6Keisuke Ieta MD, PhD,Fumiaki Tanaka MD, PhD,Naotsugu Haraguchi MD, PhD,Yoshiaki Kita MD,Hiroyuki Sakashita MD,Koshi Mimori MD, PhD,Toshifumi Matsumoto MD, PhD,Hiroshi Inoue MD, PhD,Hiroyuki Kuwano MD, PhD,Masaki Mori MD, PhD.Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer[J].Annals of Surgical Oncology.2008(2)
  • 7PC Hermann,SL Huber,T Herrler.Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer[].Cell Stem Cell.2007
  • 8LaBarge MA et al.Is CD133a marker of metastatic colon cancer stem cells?[].The Journal of Clinical Investigation.2008
  • 9Yanagisawa S,Kadouchi I,Yokomori K, et al.Identification and metastatic potential of tumor-initiating cells in malignant rhabdoid tumor of the kidney[].Clinical Cancer Research.2009
  • 10SCHNEIDER M,HUBER J,HADASCHIK B,et al.Characterization of colon cancer cells:a functional approach characterizing CD133as a potential stem cell marker[].BMC Cancer.2012

共引文献41

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部